Pfizer reports nearly $37 billion in COVID vaccine sales in 2021 The pharmaceutical giant estimates its 2022 COVID-related sales will top $54 billion. News Tim Jackson • Feb 9, 2022Feb 9, 2022
Why Ivermectin is superior to Pfizer’s antiviral pill Comedian and political commentator Jimmy Dore discusses a video by John Campbell, Ph.D. where he explains the similarities between Pfizer’s expensive new antiviral drug for COVID and ivermectin, and why ivermectin is better. Opinion Jeremy Loffredo • Nov 19, 2021